trovafloxacin has been researched along with Staphylococcal Infections in 17 studies
*Staphylococcal Infections: Infections with bacteria of the genus STAPHYLOCOCCUS. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 9 (52.94) | 18.2507 |
| 2000's | 7 (41.18) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (5.88) | 2.80 |
| Authors | Studies |
|---|---|
| Appelbaum, PC; Bhawsar, SB; Bozdogan, B; de Souza, NJ; Desai, VN; Deshpande, PK; Gupte, SV; Hooper, DC; Jacobs, MR; Jha, R; Khorakiwala, HF; Patel, MV; Shetty, N; Shukla, MC; Strahilevitz, J; Yeole, RD | 1 |
| Bhagwat, S; Bhawsar, S; Deshpande, P; Joshi, S; Patel, M; Yeole, R | 1 |
| Nathan, BR; Scheld, WM | 1 |
| Barequet, IS; Denton, P; O'Brien, TP; Osterhout, GJ; Tuli, S | 1 |
| Järvinen, A; Kardén-Lilja, M; Kuusela, P; Ruotsalainen, E; Sarna, S; Valtonen, V; Virolainen-Julkunen, A; Vuopio-Varkila, J | 1 |
| Drenning, SD; Mulazimoglu, L; Yu, VL | 1 |
| Bonilla, HF; Bradley, SF; Kauffman, CA; Zarins, LT | 1 |
| Aeschlimann, JR; Houlihan, HH; Kaatz, GW; Mercier, RC; Rybak, MJ; Seo, SM | 1 |
| Bayer, AS; Ing, M; Li, C | 1 |
| Baker, AS; Cousins, FV; D'Amico, DJ; Hooper, DC; Ng, EW; Ruoff, KL; Samiy, N; von Gunten, S | 1 |
| Chambers, HF; Chow, LL; Kim, YS; Liu, Q; Täuber, MG | 1 |
| Entenza, JM; Glauser, MP; Moreillon, P; Vouillamoz, J | 1 |
| Biavasco, F; Mingoia, M; Montanari, MP; Prenna, M; Ripa, S; Varaldo, PE | 1 |
| Peters, G; von Eiff, C | 1 |
| Eckart, RE; Fishbain, JT; Hospenthal, DR | 1 |
| Anolik, JH; Cohn, SE; Marquardt, JD; Totterman, S; Wildy, K; Zwillich, SH | 1 |
| Barzilai, A; Diamantstein, L; Gruzman, G; Keller, N; Rubinovitch, B; Rubinstein, E; Yoseph, G | 1 |
1 trial(s) available for trovafloxacin and Staphylococcal Infections
| Article | Year |
|---|---|
Methicillin-sensitive Staphylococcus aureus bacteraemia and endocarditis among injection drug users and nonaddicts: host factors, microbiological and serological characteristics.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Bacteremia; Case-Control Studies; Electrophoresis, Gel, Pulsed-Field; Endocarditis, Bacterial; Fluoroquinolones; Genotype; Humans; Methicillin; Middle Aged; Naphthyridines; Ofloxacin; Serologic Tests; Staphylococcal Infections; Staphylococcus aureus; Substance Abuse, Intravenous; Teichoic Acids | 2008 |
16 other study(ies) available for trovafloxacin and Staphylococcal Infections
| Article | Year |
|---|---|
A chiral benzoquinolizine-2-carboxylic acid arginine salt active against vancomycin-resistant Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Clinical Trials, Phase I as Topic; Dogs; Drug Resistance, Multiple, Bacterial; Female; Fluoroquinolones; Half-Life; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Methicillin Resistance; Mice; Microbial Sensitivity Tests; Mutation; Prodrugs; Quinolizines; Rats; Rats, Wistar; Staphylococcal Infections; Staphylococcus aureus; Stereoisomerism; Structure-Activity Relationship; Vancomycin Resistance | 2005 |
WCK 1152, WCK 1153: Discovery and structure activity relationship for the treatment of resistant pneumococcal and staphylococcal respiratory infections.
Topics: Anti-Bacterial Agents; DNA Gyrase; DNA Topoisomerase IV; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Piperidines; Respiratory Tract Infections; Staphylococcal Infections; Staphylococcus; Streptococcus pneumoniae; Structure-Activity Relationship | 2022 |
The efficacy of trovafloxacin versus ceftriaxone in the treatment of experimental brain abscess/cerebritis in the rat.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Area Under Curve; Brain Abscess; Ceftriaxone; Disease Models, Animal; Female; Fluoroquinolones; Half-Life; Injections, Subcutaneous; Microbial Sensitivity Tests; Naphthyridines; Rats; Rats, Wistar; Staphylococcal Infections; Staphylococcus aureus | 2003 |
Treatment of experimental bacterial keratitis with topical trovafloxacin.
Topics: Administration, Topical; Animals; Anti-Infective Agents; Biological Availability; Ciprofloxacin; Colony Count, Microbial; Cornea; Corneal Ulcer; Disease Models, Animal; Eye Infections, Bacterial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Ophthalmic Solutions; Pseudomonas Infections; Rabbits; Staphylococcal Infections; Streptococcal Infections | 2004 |
In vitro activities of two novel oxazolidinones (U100592 and U100766), a new fluoroquinolone (trovafloxacin), and dalfopristin-quinupristin against Staphylococcus aureus and Staphylococcus epidermidis.
Topics: Acetamides; Anti-Bacterial Agents; Drug Resistance, Microbial; Drug Synergism; Fluoroquinolones; Humans; Linezolid; Microbial Sensitivity Tests; Naphthyridines; Oxazoles; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus epidermidis; Time Factors; Virginiamycin | 1996 |
Susceptibility of ciprofloxacin-resistant staphylococci and enterococci to trovafloxacin.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Enterococcus faecium; Fluoroquinolones; Gram-Positive Bacterial Infections; Humans; Methicillin; Microbial Sensitivity Tests; Naphthyridines; Penicillins; Staphylococcal Infections; Staphylococcus aureus | 1996 |
Efficacy of trovafloxacin against experimental Staphylococcus aureus endocarditis.
Topics: Animals; Anti-Infective Agents; Drug Resistance, Microbial; Endocarditis, Bacterial; Fluoroquinolones; Male; Naphthyridines; Outcome Assessment, Health Care; Rabbits; Staphylococcal Infections; Staphylococcus aureus | 1998 |
Efficacy of trovafloxacin, a new quinolone antibiotic, in experimental staphylococcal endocarditis due to oxacillin-resistant strains.
Topics: Animals; Anti-Infective Agents; Disease Models, Animal; Endocarditis, Bacterial; Fluoroquinolones; Microbial Sensitivity Tests; Naphthyridines; Oxacillin; Penicillins; Rabbits; Staphylococcal Infections; Staphylococcus | 1998 |
Treatment of experimental Staphylococcus epidermidis endophthalmitis with oral trovafloxacin.
Topics: Administration, Oral; Animals; Anterior Eye Segment; Anti-Infective Agents; Biological Availability; Colony Count, Microbial; Disease Models, Animal; Endophthalmitis; Eye Infections, Bacterial; Fluoroquinolones; Male; Microbial Sensitivity Tests; Naphthyridines; Rabbits; Random Allocation; Retina; Staphylococcal Infections; Staphylococcus epidermidis; Vitreous Body | 1998 |
Comparative efficacy of trovafloxacin in experimental endocarditis caused by ciprofloxacin-sensitive, methicillin-resistant Staphylococcus aureus.
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Endocarditis, Bacterial; Fluoroquinolones; Heart; Methicillin Resistance; Microbial Sensitivity Tests; Naphthyridines; Rabbits; Staphylococcal Infections; Staphylococcus aureus | 1998 |
Efficacy of trovafloxacin in treatment of experimental staphylococcal or streptococcal endocarditis.
Topics: Animals; Anti-Infective Agents; Blood Proteins; Ciprofloxacin; Endocarditis, Subacute Bacterial; Fluoroquinolones; Methicillin Resistance; Microbial Sensitivity Tests; Naphthyridines; Penicillin Resistance; Protein Binding; Rats; Staphylococcal Infections; Staphylococcus aureus; Time Factors | 1999 |
Antistaphylococcal and antistreptococcal killing kinetics of ciprofloxacin, ofloxacin, sparfloxacin, and trovafloxacin.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Quinolones; Staphylococcal Infections; Staphylococcus aureus; Streptococcal Infections; Streptococcus pneumoniae; Streptococcus pyogenes | 1998 |
Comparative in-vitro activities of moxifloxacin, trovafloxacin, quinupristin/dalfopristin and linezolid against staphylococci.
Topics: Acetamides; Anti-Bacterial Agents; Aza Compounds; Fluoroquinolones; Humans; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Moxifloxacin; Naphthyridines; Oxazoles; Oxazolidinones; Quinolines; Staphylococcal Infections; Staphylococcus; Virginiamycin | 1999 |
Response of complicated methicillin-resistant Staphylococcus aureus endocarditis to the addition of trovafloxacin.
Topics: Adult; Anti-Infective Agents; Endocarditis, Bacterial; Fluoroquinolones; Humans; Lung Abscess; Male; Methicillin; Methicillin Resistance; Naphthyridines; Penicillins; Staphylococcal Infections | 2000 |
Multifocal Staphylococcus aureus infection originating from the sacroiliac joint in a patient with rheumatoid arthritis.
Topics: Anti-Infective Agents; Arthritis, Infectious; Cefazolin; Cephalosporins; Drug Therapy, Combination; Fluoroquinolones; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Naphthyridines; Rifampin; Sacroiliac Joint; Staphylococcal Infections; Staphylococcus aureus; Sulfamethoxazole; Trimethoprim | 2001 |
The effect of albumin, globulin, pus and dead bacteria in aerobic and anaerobic conditions on the antibacterial activity of moxifloxacin, trovafloxacin and ciprofloxacin against Streptococcus pneumoniae, Staphylococcus aureus and Escherichia coli.
Topics: Albumins; Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Globulins; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Moxifloxacin; Naphthyridines; Pneumococcal Infections; Quinolines; Staphylococcal Infections; Staphylococcus aureus; Streptococcus pneumoniae; Suppuration | 2000 |